Quest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil rises as Trump repeats Iran attack threat
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Quest Diagnostics (DGX) PT Lowered to $121 at Credit Suisse
October 24, 2018 8:47 AM EDTCredit Suisse analyst A.J. Rice lowered the price target on Quest Diagnostics (NYSE: DGX) to $121.00 (from $128.00) while maintaining an Outperform rating following results.
Rice said Long-term Tailwinds Still in Play, Despite a Short-term Speed Bump.
... MoreQuest Diagnostics (DGX) Reports Acquisition of Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
October 22, 2018 9:32 AM EDT3 Quest Diagnostics (NYSE: DGX) today announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, a leading regional provider of healthcare services.
Patients and providers in central Michigan will have access to Quest's broader range of diagnostic services, a... More
BofA/Merrill Lynch Reinstates Quest Diagnostics (DGX) at Buy
October 19, 2018 6:09 AM EDTBofA/Merrill Lynch analyst Derik de Bruin reinstates coverage on Quest Diagnostics (NYSE: DGX) with a Buy rating and a price target of $116.00.
For an analyst ratings summary and ratings history on Quest Diagnostics... More
